Funding Opportunities

Title Announcement # Expiration Datesort descending Research Focus
U.S.-China Program for Biomedical Collaborative Research RFA-CA-19-009 (R01 Clinical Trial Optional) 02/22/2019
    • Cancer Biomarkers
NCI Clinical and Translational Exploratory/Developmental Studies PAR-18-020 (R21 Clinical Trial Optional) 03/23/2019
    • Lung and Upper Aerodigestive Cancer
    • Prostate and Urologic Cancer
    • Breast and Gynecologic Cancer
    • Gastrointestinal and Other Cancers
    • Clinical and Translational
Mechanisms of Disparities in Chronic Liver Diseases and Cancer PAR-17-150 (R21)
PAR-17-151 (R01)
04/05/2019
    • Cancer Biomarkers
Mechanisms, Models, Measurement, & Management in Pain Research PA-18-141 (R01 Clinical Trial Optional)
PA-18-159 (R21 Clinical Trial Optional)
05/08/2019
    • Supportive and Palliative Care Research
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control PAR-18-018 (R21 Clinical Trial Optional) 05/08/2019
    • Supportive and Palliative Care Research
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection PAR-16-276 (R01)
PAR-16-277 (R21)
06/14/2019
    • Cancer Biomarkers
Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach PAR-18-616 (U01 Clinical Trial Optional) 07/06/2019
    • Breast and Gynecologic Cancer
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research PA-18-034 (R01 Clinical Trial Optional) 09/08/2019
    • Nutritional Science
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities PA-16-258 (R21) 09/08/2019
    • Supportive and Palliative Care Research
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure PAR-18-727 (R01 Clinical Trial Optional) 09/28/2019
    • Nutritional Science
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research RFA-CA-19-022 (R33 Clinical Trials Not Allowed) 09/28/2019
    • Cancer Biomarkers
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-19-020 (R33 Clinical Trials Not Allowed) 09/28/2019
    • Cancer Biomarkers
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-19-019 (R21 Clinical Trials Not Allowed) 09/28/2019
    • Cancer Biomarkers
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research RFA-CA-19-021 (R21 Clinical Trials Not Allowed) 09/28/2019
    • Cancer Biomarkers
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems PAR-18-009 (R01 Clinical Trial Optional) 11/06/2019
    • Cancer Biomarkers
National Cancer Institute Program Project Applications PAR-18-290 (P01 Clinical Trial Optional) 01/08/2020
    • Chemopreventive Agent Development
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) PA-18-004 (R01 Clinical Trial Optional)
PA-18-004 (R21 Clinical Trial Optional)
01/08/2020
    • Supportive and Palliative Care Research
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) PA-18-817 04/16/2020
    • Nutritional Science
Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) PA-18-818 04/16/2020
    • Nutritional Science
Advancing the Science of Geriatric Palliative Care PA-18-502 (R01 - Clinical Trial Optional)
PA-18-503 (R21 - Clinical Trial Optional)
05/08/2020
    • Supportive and Palliative Care Research
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies PA-18-025 (R01 Clinical Trial Optional) 05/08/2020
    • Chemopreventive Agent Development
    • Breast and Gynecologic Cancer
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) PA-18-842 09/11/2020
    • Lung and Upper Aerodigestive Cancer
    • Prostate and Urologic Cancer
    • Breast and Gynecologic Cancer
    • Gastrointestinal and Other Cancers
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) PAR-18-317 10/09/2020
    • Cancer Biomarkers
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed PAR-18-310 10/09/2020
    • Cancer Biomarkers
Basic Research in Cancer Health Disparities PAR-18-654 (R01 Clinical Trials Not Allowed)
PAR-18-655 (R21 Clinical Trial Not Allowed)
11/20/2020
    • Community Oncology and Prevention Trials
Biology of Lung, and Head and Neck Preneoplasias PA-17-459 (R01)
PA-17-460 (R21 - Clinical Trial Not Allowed)
01/08/2021
    • Lung and Upper Aerodigestive Cancer
Symptom Cluster Characterization in Chronic Conditions PA-17-461 (R21)
PA-17-462 (R01)
01/08/2021
    • Supportive and Palliative Care Research
Cancer Prevention and Control Clinical Trials Grant Program PAR-18-559 (R01 Clinical Trial Required) 01/08/2021
    • Breast and Gynecologic Cancer
Exploratory/Developmental Clinical Research Grants in Obesity PA-18-720 (R21 Clinical Trial Optional) 05/08/2021
    • Nutritional Science
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression PA-18-738 (R01 Clinical Trial Optional)
PA-18-739 (R21 Clinical Trial Optional)
05/08/2021
    • Nutritional Science
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine PAR-18-841 (U24 - Clinical Trial Optional) 06/15/2021
    • Cancer Biomarkers
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research PAR-18-913 (U01 Clinical Trial Not Allowed) 08/12/2021
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    • Early Detection
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research PA-18-876 (R01 Clinical Trial Not Allowed) 09/08/2021
    • Nutritional Science
Diet and Physical Activity Assessment Methodology PA-18-856 (R01 Clinical Trial Not Allowed)
PAR-18-857 (R21 Clinical Trial Not Allowed)
09/08/2021
    • Nutritional Science
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-892 (R21 Clinical Trial Optional)
PAR-18-893 (R01 Clinical Trial Optional)
09/08/2021
    • Nutritional Science
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research PA-18-902 (R01 Clinical Trial Optional) 09/08/2021
    • Cancer Biomarkers
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-19-113 (R01 Clinical Trial Optional) 01/08/2022
    • Cancer Biomarkers
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-111 (R21 Clinical Trial Optional)
PA-19-112 (R01 Clinical Trial Optional)
01/08/2022
    • Supportive and Palliative Care Research